| __timestamp | Taro Pharmaceutical Industries Ltd. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 179279000 | 4050200000 |
| Thursday, January 1, 2015 | 186359000 | 5047100000 |
| Friday, January 1, 2016 | 171785000 | 6078400000 |
| Sunday, January 1, 2017 | 208136000 | 6931500000 |
| Monday, January 1, 2018 | 198405000 | 6861900000 |
| Tuesday, January 1, 2019 | 224169000 | 7056300000 |
| Wednesday, January 1, 2020 | 245044000 | 8149300000 |
| Friday, January 1, 2021 | 252314000 | 12310800000 |
| Saturday, January 1, 2022 | 268225000 | 9765700000 |
| Sunday, January 1, 2023 | 304629000 | 8988300000 |
| Monday, January 1, 2024 | 324203000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Viatris Inc. and Taro Pharmaceutical Industries Ltd. have shown distinct trends in their cost of revenue. Viatris Inc., a major player, saw its cost of revenue peak in 2021, reaching approximately 12.3 billion, a significant 52% increase from 2014. However, by 2023, this figure had decreased by about 27% to 9 billion. In contrast, Taro Pharmaceutical Industries Ltd. experienced a steady rise, with costs increasing by 81% from 2014 to 2023, reaching around 324 million. This divergence highlights the different strategic approaches and market challenges faced by these companies. Notably, data for 2024 is incomplete, indicating potential shifts in the coming years. Investors and analysts should watch these trends closely as they reflect broader industry movements.
Cost of Revenue Comparison: AstraZeneca PLC vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Pfizer Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Cost of Revenue Comparison: Viatris Inc. vs Exelixis, Inc.
Analyzing Cost of Revenue: Viatris Inc. and Lantheus Holdings, Inc.
Cost of Revenue Trends: Viatris Inc. vs HUTCHMED (China) Limited
Cost Insights: Breaking Down Viatris Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Viatris Inc. vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Viatris Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.